Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial. (Q44173880)
scientific article published on 10 March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial. |
scientific article published on 10 March 2009 |
Statements
Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: a phase IIa trial (English)
Ian D Davis
Ben Brady
Michael Millward
Birte K Skrumsager
Ulrik Mouritzen
Lasse Tengbjerg Hansen
Kresten Skak
Dorthe Lundsgaard
Klaus Stensgaard Frederiksen
Paul E G Kristjansen